CD33
CD33, also known as SIGLEC3, Siglec-3 or p67, is a sialic-acid-binding immunoglobulin-like lectin that mediates cell-cell interactions and helps keep immune cells in a resting state. It signals through cytoplasmic ITIMs to recruit tyrosine phosphatases. Browse Assay Genie's current range of CD33 research reagents below, or read on for the biology behind the target.
CD33 is a Siglec that mediates cell-cell interactions and maintains immune cells in a resting state. It preferentially recognises and binds alpha-2,3- and, more avidly, alpha-2,6-linked sialic acid-bearing glycans. When ligands such as C1q or sialylated glycoproteins are engaged, two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in the CD33 cytoplasmic tail are phosphorylated by Src-like kinases such as LCK.
These phosphorylated motifs provide docking sites for the protein-tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2. The recruited phosphatases are activated and regulate downstream pathways by dephosphorylating signalling molecules. One of the repressive effects of CD33 on monocyte activation requires phosphoinositide 3-kinase (PI3K). Consistent with this, NCBI Gene annotates the CD33 gene product with protein phosphatase binding, protein tyrosine phosphatase activator and sialic acid binding activities. It is also linked to immune response-regulating signalling and to negative regulation of cytokine production and monocyte activation.
CD33 belongs to the immunoglobulin superfamily and the SIGLEC family. HGNC places it in the CD molecules, V-set domain containing and sialic acid binding Ig-like lectin gene groups. Its previous name was CD33 antigen (gp67), and other aliases include FLJ00391 and CD33rSiglec. UniProt lists the CD33 protein at the cell membrane and in peroxisomes. NCBI Gene also reports it in the Golgi apparatus and on the external side of the plasma membrane. The mouse ortholog is Cd33.
CD33 uses ITIM phosphorylation and SHP-1/SHP-2 recruitment to restrain immune cell activity, making it a model inhibitory receptor.
CD33 represses monocyte activation through a mechanism that requires PI3K, so it is relevant to work on myeloid cell regulation.
As a Siglec, CD33 recognises alpha-2,3- and alpha-2,6-linked sialylated glycans, supporting studies of lectin-glycan interactions.
CD33 is involved in negative regulation of cytokine production, which is relevant to research on how immune responses are dampened.
CD33 is a Siglec that mediates cell-cell interactions and keeps immune cells in a resting state. Ligand binding leads to ITIM phosphorylation by Src-like kinases such as LCK. This recruits SHP-1 and SHP-2, which dephosphorylate signalling molecules and repress activation, including in monocytes.
CD33 is also called SIGLEC3, SIGLEC-3, p67, FLJ00391 and CD33rSiglec. Its HGNC name is CD33 molecule, UniProt calls it myeloid cell surface antigen CD33, and a previous name was CD33 antigen (gp67). Sialic-acid-binding Ig-like lectin 3 is the full Siglec-3 designation.
A mouse ortholog, Cd33, is recorded for the human gene. The source data do not give a rat ortholog. If you work in a particular species, check the datasheet of any product for its validated reactivity.
Other CD molecules, myeloid markers and immune receptors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P20138; product specifications from Assay Genie datasheets.